Company
Does Pliant Therapeutics Inc (NASDAQ: PLRX) Still Look Attractive After A 2.61% Selloff Last Week?
During the last session, Pliant Therapeutics Inc (NASDAQ:PLRX)’s traded shares were 0.33 million, with the beta value of the company hitting 1.09. At the end
